首页 | 本学科首页   官方微博 | 高级检索  
检索        


Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis
Authors:Jinjung Choi  Carlo Selmi  Patrick S C Leung  Thomas P Kenny  Tania Roskams
Institution:1. Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis, Davis, CA, USA;2. Division of Rheumatology, CHA University Medical Center, Bundang, Korea;3. Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano, Italy;4. BIOMETRA Department, University of Milan, Milano, Italy;5. Translational Cell and Tissue Research, University of Leuven, Leuven, Belgium
Abstract:Chemokines represent a major mediator of innate immunity and play a key role in the selective recruitment of cells during localized inflammatory responses. Beyond critical extracellular mediators of leukocyte trafficking, chemokines and their cognate receptors are expressed by a variety of resident and infiltrating cells (monocytes, lymphocytes, NK cells, mast cells, and NKT cells). Chemokines represent ideal candidates for mechanistic studies (particularly in murine models) to better understand the pathogenesis of chronic inflammation and possibly become biomarkers of disease. Nonetheless, therapeutic approaches targeting chemokines have led to unsatisfactory results in rheumatoid arthritis, while biologics against pro-inflammatory cytokines are being used worldwide with success. In this comprehensive review we will discuss the evidence supporting the involvement of chemokines and their specific receptors in mediating the effector cell response, utilizing the autoimmune/primary biliary cholangitis setting as a paradigm.
Keywords:Innate immunity  chemokine receptor  tolerance breakdown  biologics  monoclonal antibody  autoimmune cholangitis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号